PDZK1 acts as a tumor suppressor in gastric cancer and renal cancer, but in esophageal adenocarcinoma, breast cancer, and multiple myelomas (MMs), the overexpression of PDZK1 promotes cancer development or drug resistance (71–73). The gene discussed is PDZK1; the disease is esophageal adenocarcinoma.